Trial intelligence / Profile preview

Preemptive Butorphanol for Postoperative Pain in Gynecological Laparoscopy

NCT06524596Completed

Sponsor
Wuhan Women and Children's Health Care Center
Start
Jan 2022
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of butorphanol in postoperative pain (2 arms), sponsored by Wuhan Women and Children's Health Care Center. Primary endpoint: Visual Analogue Scale Scores for Pain at 24 hours. Started Jan 2022; status: completed.

02

Drugs

butorphanol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06524596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06524596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call